Table 1.

Distribution of molecular phenotypes in the cases of BC with MC of each series.

References	N	HR-Positive/HER2-Negative N (%)	HER2-Positive N (%)	TN N (%)	Unknown N (%)
Lefebvre et al. [20]	28	17 (61)	2 (7)	7 (25)	2 (7)
Yates et al. [21]	19	9 (47)	2 (10)	5 (26)	3 (16)
Kong et al. [22]	125	53 (42.4)	43 (34.4)	29 (23.2)
Luna et al. [23]	26	7 (27)	7 (27)	10 (39)	2 (7)